Consolidated Statement Of Income

Modalis Therapeutics Corporation - Filing #7581546

Concept 2022-01-01 to
2022-06-30
2021-01-01 to
2021-06-30
Consolidated statement of income
Statement of income
Operating expenses
Selling, general and administrative expenses
130,049,000 JPY
129,412,000 JPY
Operating expenses
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
19,980,000 JPY
19,230,000 JPY
Ordinary profit (loss)
-780,483,000 JPY
-464,982,000 JPY
Operating profit (loss)
-868,457,000 JPY
-477,318,000 JPY
General and administrative expenses
Salaries
Operating expenses
Research and development expenses
778,908,000 JPY
349,005,000 JPY
Selling, general and administrative expenses
Non-operating income
Interest income
27,000 JPY
27,000 JPY
Other
299,000 JPY
63,000 JPY
Non-operating income
91,227,000 JPY
13,129,000 JPY
Extraordinary income
JPY
485,881,000 JPY
Non-operating expenses
Interest expenses
2,331,000 JPY
JPY
Non-operating expenses
3,253,000 JPY
793,000 JPY
Share issuance costs
654,000 JPY
793,000 JPY
Profit (loss) before income taxes
-780,483,000 JPY
20,899,000 JPY
Income taxes - current
609,000 JPY
1,269,000 JPY
Extraordinary income
Income taxes - deferred
-5,397,000 JPY
1,927,000 JPY
Income taxes
-4,788,000 JPY
3,196,000 JPY
Profit (loss)
-775,695,000 JPY
17,702,000 JPY
Profit (loss) attributable to owners of parent
-775,695,000 JPY
17,702,000 JPY
Other comprehensive income
Foreign currency translation adjustment
28,819,000 JPY
4,618,000 JPY
Other comprehensive income
28,819,000 JPY
4,618,000 JPY
Profit attributable to
Comprehensive income
-746,875,000 JPY
22,321,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-746,875,000 JPY
22,321,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.